BRPI0404688A - Composição para tratamento vaginal, uso da mesma, óvulo de tratamento, creme de tratamento, tampão vaginal para tratamento, e, forro de calcinha para tratamento - Google Patents

Composição para tratamento vaginal, uso da mesma, óvulo de tratamento, creme de tratamento, tampão vaginal para tratamento, e, forro de calcinha para tratamento

Info

Publication number
BRPI0404688A
BRPI0404688A BR0404688-9A BRPI0404688A BRPI0404688A BR PI0404688 A BRPI0404688 A BR PI0404688A BR PI0404688 A BRPI0404688 A BR PI0404688A BR PI0404688 A BRPI0404688 A BR PI0404688A
Authority
BR
Brazil
Prior art keywords
treatment
vaginal
composition
cream
egg
Prior art date
Application number
BR0404688-9A
Other languages
English (en)
Inventor
Peter-Hansen Volkmann
Original Assignee
Peter-Hansen Volkmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter-Hansen Volkmann filed Critical Peter-Hansen Volkmann
Publication of BRPI0404688A publication Critical patent/BRPI0404688A/pt
Publication of BRPI0404688B1 publication Critical patent/BRPI0404688B1/pt
Publication of BRPI0404688B8 publication Critical patent/BRPI0404688B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO PARA TRATAMENTO VAGINAL, USO DA MESMA, óVULO DE TRATAMENTO, CREME DE TRATAMENTO, TAMPãO VAGINAL PARA TRATAMENTO, E, FORRO DE CALCINHA PARA TRATAMENTO". A presente invenção refere-se a uma composição para tratamento vaginal. Particularmente, a invenção refere-se a uma composição para tratamento vaginal, que é introduzida em forma de um óvulo, de um creme ou de um ung³ento, ou com o tampão, diretamente na vagina, ou sobre um forro de calcinha diante da vagina. Além disso, a invenção refere-se a um bastonete para uretra com uma composição para tratamento vaginal correspondente.
BRPI0404688A 2003-11-03 2004-10-29 composição para tratamento vaginal, uso da mesma, óvulo de tratamento, creme de tratamento, tampão vaginal para tratamento, e, forro de calcinha para tratamento BRPI0404688B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03025152A EP1506781B1 (de) 2003-11-03 2003-11-03 Vaginalpflegezusammensetzung

Publications (3)

Publication Number Publication Date
BRPI0404688A true BRPI0404688A (pt) 2005-07-12
BRPI0404688B1 BRPI0404688B1 (pt) 2016-10-11
BRPI0404688B8 BRPI0404688B8 (pt) 2021-05-25

Family

ID=33560815

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0404688A BRPI0404688B8 (pt) 2003-11-03 2004-10-29 composição para tratamento vaginal, uso da mesma, óvulo de tratamento, creme de tratamento, tampão vaginal para tratamento, e, forro de calcinha para tratamento

Country Status (23)

Country Link
US (2) US20050095232A1 (pt)
EP (1) EP1506781B1 (pt)
JP (1) JP4863612B2 (pt)
KR (1) KR101092731B1 (pt)
CN (1) CN1636577B (pt)
AR (1) AR046218A1 (pt)
AT (1) ATE289514T1 (pt)
AU (1) AU2004226910B2 (pt)
BR (1) BRPI0404688B8 (pt)
CA (1) CA2486473C (pt)
DE (1) DE50300325D1 (pt)
DK (1) DK1506781T3 (pt)
ES (1) ES2237732T3 (pt)
IL (1) IL164637A0 (pt)
MX (1) MXPA04010893A (pt)
NO (1) NO332400B1 (pt)
NZ (1) NZ536261A (pt)
PL (1) PL213027B1 (pt)
PT (1) PT1506781E (pt)
RU (1) RU2369389C2 (pt)
SG (1) SG111283A1 (pt)
SI (1) SI1506781T1 (pt)
ZA (1) ZA200408882B (pt)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) * 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
RU2300370C1 (ru) * 2006-02-14 2007-06-10 Зоя Ивановна Микашинович Способ лечения атрофического кольпита
DE102006017672B4 (de) * 2006-04-12 2008-07-03 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Verwendung als Laxativum
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
MX2009000053A (es) * 2006-07-12 2009-02-23 Controlled Therapeutics Sct Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
WO2008027404A2 (en) * 2006-08-29 2008-03-06 Playtex Products, Inc. Tampon removal device
US8062631B2 (en) * 2006-09-28 2011-11-22 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US8409557B2 (en) 2006-09-28 2013-04-02 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US20080274162A1 (en) * 2007-05-04 2008-11-06 Jeffrey Nessa Method, composition, and delivery mode for treatment of prostatitis and other urogenital infections using a probiotic rectal suppository
US20090156987A1 (en) * 2007-12-14 2009-06-18 Mclean Barbara Wanamaker Apparatus and method of delivery of substances into target tissue
RU2367454C1 (ru) * 2008-01-09 2009-09-20 Александр Николаевич Забокрицкий Средство интимной гигиены "фемивит"
EP2243482A1 (en) * 2009-04-20 2010-10-27 Polichem SA Use of nifuratel to treat infections caused by atopobium species
GB0915315D0 (en) * 2009-09-03 2009-10-07 Univ Manchester Use of non-digestible oligosaccharides
EP2505188A1 (en) * 2009-12-02 2012-10-03 Bettina Heil Suppository for rectal, vaginal or urethral administration
US8846723B2 (en) 2010-07-29 2014-09-30 Eastman Chemical Company Esters of O-substituted hydroxy carboxylic acids and preparations thereof
EP2420228A1 (en) 2010-08-05 2012-02-22 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences AG Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer
US8613940B2 (en) 2010-09-03 2013-12-24 Eastman Chemical Company Carbonate derivatives as skin care
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
US8329938B2 (en) * 2011-02-21 2012-12-11 Eastman Chemical Company Hydroxyalkanoic acid and hydroxyalkanoice acid oligomer esters of retinol
PL2685994T3 (pl) * 2011-03-17 2016-05-31 Probiotical Spa Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
JP6400470B2 (ja) 2011-05-16 2018-10-03 ジェネロン（シャンハイ）コーポレイション リミテッド 多重特異性Ｆａｂ融合タンパク質および使用法
WO2013012614A1 (en) * 2011-07-21 2013-01-24 University Of Miami Vaginal tissue rejuvenation compositions and methods
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
FR2981273B1 (fr) * 2011-10-14 2013-12-20 Gilles Andre Yves Bhat Nouvelle composition pour les muqueuses: tocopherol, macerat huileux de fleurs de calendula dans de l'huile de rose musquee, palmitate de retinol, ubiquinone, ascorbyl palmitate et lactobacillus
US20130108599A1 (en) * 2011-10-31 2013-05-02 Tamyra Comeaux Herbal Vaginal Compositions
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
RU2504580C1 (ru) * 2012-08-01 2014-01-20 Вячеслав Михайлович Абрамов ПРОБИОТИЧЕСКИЕ ШТАММЫ Lactobacillus И ИХ КОНСОРЦИУМ ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ УРОГЕНИТАЛЬНЫХ ИНФЕКЦИОННЫХ ЗАБОЛЕВАНИЙ У ЖЕНЩИН
CN103114439B (zh) * 2013-01-24 2015-01-07 量子高科(中国)生物股份有限公司 一种具有生物调节作用的无纺布及其制备方法
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
CN103735601B (zh) * 2013-12-31 2016-10-05 哈尔滨欧替药业有限公司 瓦松阴道膨胀栓及其制备方法和检测方法
CN110840903B (zh) 2014-03-13 2021-08-31 深圳优丽康生物技术有限公司 异麦芽酮糖在制备选择性促进乳杆菌生长用组合物上的用途及该组合物
EP3179981A1 (en) 2014-05-15 2017-06-21 Grünenthal GmbH Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ
DE102014119576A1 (de) * 2014-12-23 2016-06-23 Ernst-Moritz-Arndt-Universität Greifswald Pharmazeutische Arzneimittelform zur Applikation auf Schleimhäuten
CN105434605A (zh) * 2015-06-03 2016-03-30 马南行 一种阴道护理平衡治疗的组合物及其制备方法
US10857094B2 (en) * 2015-09-02 2020-12-08 Eric A. Weiss Lubricating and moisturizing composition for human use
CN105232231A (zh) * 2015-11-10 2016-01-13 湖北民族学院 一种富硒卫生用品及其制备方法
CN105748492A (zh) * 2016-02-16 2016-07-13 王冬颖 一种抑制白色念珠菌生长的糖配制剂
WO2017157305A1 (en) 2016-03-15 2017-09-21 Generon (Shanghai) Corporation Ltd. Multispecific fab fusion proteins and use thereof
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
US20190117690A1 (en) 2016-04-06 2019-04-25 The University State Of America As Represented By The Secretary Of The Department Of Health And Hum Use of heterodimeric il-15 in adoptive cell transfer
KR101784847B1 (ko) * 2016-05-10 2017-10-13 주식회사 하우동천 질염 예방 및 치료용 유산균 함유 조성물 및 이의 용도
TW201825511A (zh) 2016-09-09 2018-07-16 美商艾斯合顧問有限公司 表現免疫檢查點調節子的溶瘤病毒
IT201700037319A1 (it) * 2017-04-05 2018-10-05 Moss S P A Composizione naturale per uso in ginecologia
DE102017121066A1 (de) * 2017-08-07 2019-02-07 Boris Vestweber Zusammensetzung, insbesondere zur Pflege des Intim- oder Vaginalbereichs
CN110353885A (zh) * 2018-04-11 2019-10-22 常州英莱克斯生物工程有限公司 一种无需施用器吸湿效果好的卫生棉条
GR1009621B (el) * 2018-07-25 2019-10-23 Ιουλια Κλεωνος Τσετη Συνθεσεις για τοπικη χρηση, που περιεχουν συνδυασμους βορικου οξεος, ελαιου τεϊοδεντρου, πανθενολης και μπισαμπολολης, χρησιμες για την αντιμετωπιση μυκητιασικων λοιμωξεων
EP3847196A4 (en) 2018-09-07 2023-01-04 ITabMed (HK) Limited BISPECIFIC ANTIGEN BINDING PROTEINS AND USES THEREOF
WO2020132810A1 (en) 2018-12-24 2020-07-02 Generon (Shanghai) Corporation Ltd. Multispecific antigen binding proteins capable of binding cd19 and cd3, and use thereof
CN113613664B (zh) 2019-03-01 2025-11-18 阿奇洛伊斯生物制药公司 在抗原特异性免疫细胞中调节cd160功能的方法及其用途
CN110840918A (zh) * 2019-11-25 2020-02-28 无锡宾西利悦科技有限公司 一种女性阴道微生态组合物
CN114015674B (zh) 2021-11-02 2024-08-30 辉大(上海)生物科技有限公司 一种CRISPR-Cas12i系统

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS588018A (ja) * 1981-07-07 1983-01-18 Akira Yamauchi 下剤
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
SE9100364L (sv) * 1991-02-05 1992-08-06 Bac Dev In Sweden Ab Tampong eller binda impregnerad med en kultur av levande mjoelksyrabakterier i avsikt att minska risken foer urogenitala infektioner
JPH0710740A (ja) * 1993-04-26 1995-01-13 Meiji Milk Prod Co Ltd メラニン生成抑制剤
US5702714A (en) * 1995-06-07 1997-12-30 Goss; Louis Skin conditioner
JP4008974B2 (ja) * 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
PT956858E (pt) * 1998-04-30 2002-04-29 Renata Maria Anna Caval Vesely Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
JP2000217566A (ja) * 1999-01-25 2000-08-08 Bhph Co Ltd ラクトバチラスクリアランスを培養するための培養基および該菌種の保存方法
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
CZ288454B6 (en) * 1999-08-10 2001-06-13 Miroslav Mvdr Mahel Healing preparations for early postnatal problems and mastitis of domestic animals
EP1118340A1 (en) 2000-01-18 2001-07-25 The Procter & Gamble Company Articles having an odour control system comprising lactic-acid producing micro-organisms and an odour absorbing agent
US6967025B2 (en) * 2000-01-18 2005-11-22 The Procter & Gamble Company Articles with spores exhibiting antagonistic properties against pathogens and/or spores forming micro-organisms
BR0002018A (pt) 2000-05-26 2002-01-02 Eltecom Empreendimentos E Part Uso de composições farmacêuticas a partir de saccharomyces cerevisiae para o tratamento de infecções vaginais
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa
RU2182008C1 (ru) * 2000-10-20 2002-05-10 Самойленко Игорь Иннокентьевич Вводимая перорально, ректально или интравагинально композиция, содержащая живые бактерии
US20020192310A1 (en) * 2001-02-02 2002-12-19 Bland Jeffrey S. Medical composition for managing hormone balance
JP3484428B2 (ja) * 2001-05-31 2004-01-06 明王物産株式会社 酵母エキスの製造方法
AU2003216213B2 (en) * 2002-02-07 2008-10-02 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
PL212647B1 (pl) 2002-03-21 2012-11-30 Bifodan As Kompozycja farmaceutyczna, szczep Lactobacillus paracasei Lbp PB01 oraz szczep Lactobacillus paracasei Lbp PB01 w polaczeniu ze szczepem Lactobacillus acidophilus Lba EB01, produkt chlonny zawierajacy te kompozycje oraz produkt nabialowy, produkt nutraceutyczny i czynnosciowy produkt zywnosciowy zawierajace ten szczep albo te dwa szczepy, a takze zastosowanie tego szczepu albo tych dwóch szczepów
AU2003215472A1 (en) 2002-03-28 2003-10-13 Jeremy Burton Lactobacillus iners for the enhancement of urogenital health
US20040071679A1 (en) * 2002-10-15 2004-04-15 Claudio De Simone Identifying and treating vaginal infections
CA2508712A1 (en) * 2002-12-13 2004-07-01 L'oreal Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration
US20050180962A1 (en) * 2003-01-30 2005-08-18 Eyal Raz Inactivated probiotic bacteria and methods of use thereof
JP4712289B2 (ja) * 2003-08-26 2011-06-29 株式会社エイ・エル・エイ 免疫促進用組成物

Also Published As

Publication number Publication date
NZ536261A (en) 2005-03-24
ZA200408882B (en) 2005-09-28
BRPI0404688B8 (pt) 2021-05-25
RU2369389C2 (ru) 2009-10-10
PL213027B1 (pl) 2012-12-31
US7670606B2 (en) 2010-03-02
AU2004226910A1 (en) 2005-05-19
JP2005139176A (ja) 2005-06-02
CA2486473C (en) 2014-01-21
CA2486473A1 (en) 2005-05-03
IL164637A0 (en) 2005-12-18
EP1506781A1 (de) 2005-02-16
RU2004132058A (ru) 2006-04-10
JP4863612B2 (ja) 2012-01-25
SG111283A1 (en) 2005-05-30
CN1636577B (zh) 2012-05-09
BRPI0404688B1 (pt) 2016-10-11
AU2004226910B2 (en) 2009-12-10
DK1506781T3 (da) 2005-06-13
NO332400B1 (no) 2012-09-10
HK1079109A1 (en) 2006-03-31
SI1506781T1 (pt) 2005-08-31
EP1506781B1 (de) 2005-02-23
KR101092731B1 (ko) 2011-12-09
MXPA04010893A (es) 2005-10-26
US20050095232A1 (en) 2005-05-05
US20070059298A1 (en) 2007-03-15
ES2237732T3 (es) 2005-08-01
CN1636577A (zh) 2005-07-13
AR046218A1 (es) 2005-11-30
PT1506781E (pt) 2005-07-29
ATE289514T1 (de) 2005-03-15
PL370970A1 (pl) 2005-05-16
KR20050042455A (ko) 2005-05-09
NO20044699L (no) 2005-05-04
DE50300325D1 (de) 2005-03-31

Similar Documents

Publication Publication Date Title
BRPI0404688B8 (pt) composição para tratamento vaginal, uso da mesma, óvulo de tratamento, creme de tratamento, tampão vaginal para tratamento, e, forro de calcinha para tratamento
BR0109983A (pt) Estratrienos substituìdos por 8.beta-hidrocarbila como estrogênios seletivamente eficientes
BRPI0411295A (pt) compostos e seu uso na terapia
Phillips et al. Hormonal effects on skin aging
BRPI0416205A (pt) uso de antibióticos como adjuvantes de vacina
BR0010113A (pt) Preparações para uso externo na pele
BRPI0311323B8 (pt) composto inibidor de c-aril glicosídeo sglt2, composição farmacêutica e combinação
BR0015194A (pt) Uso de um inibidor de egfr-tirosina-quinase, e, métodos para redução da transformação de células epiteliais e para causar reversão substancial de tecido epitelial
BRPI0114927B8 (pt) composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição
BR0308663A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção de doenças vasculares periféricas
BR0214714A (pt) absorvente de alta inchação que muda uma vestimenta tipo roupa ìntima fina em uma vestimenta tipo fralda espessa
BRPI0511967A (pt) usos de derivados de 5-amino-2,4,7-trioxo-3,4,7,8-tetrahidro-2h-pirido[2,3-d] pirimidina e compostos relacionados para o tratamento de cáncer, suas composições farmacêuticas, embalagens comerciais e respectivo kit
BR0211039A (pt) Composição condicionadora para os cabelos e uso de uma composição condicionadora para os mesmos
Manonai et al. The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial
BR0316203A (pt) Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
BRPI0415713A (pt) mio-inositol hexafosfato para uso tópico
BR0113649A (pt) Processo para aumentar a testosterona e as relacionadas concentrações de esteróide em mulheres
BR0212374A (pt) Oxintomodulina para a prevenção ou para o tratamento do excesso de peso
BRPI0516954A (pt) inibidores de c-aril glicosìdeos sgl t2 e método
BR112012019208A2 (pt) prótese para a parede posterior feminina.
BR0210013A (pt) Gel oftálmico de pirenzepina
BR0114665A (pt) Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio
BRPI0518328A2 (pt) agente de contraste, composiÇço farmacÊutica, uso de um agente de contraste, mÉtodo para gerar imagens realÇadas de um corpo animal ou humano, e, kit para a preparaÇço de um composiÇço radiofarmacÊutica
BR0008437A (pt) Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos
WO2002063954A3 (en) USE OF β-LACTAMASE INHIBITORS AS NEUROPROTECTANTS

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/10/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/10/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B15V Prolongation of time limit allowed
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2694 DE 23-08-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.